InstructorRoyed Training
TypeOnline Course
Student Enrolled5
Price$830 / 58100 INR.
Buy NowBook Now
Loading
Loading
Biopharma Global Business certification by royed training

Introduction

Who should attend this course?

Core Learning Areas

Features

Related Courses

About Pharma Management

Biopharma Global Business Course by Royed Training

The Executive Program in Biopharma Global Business by Royed Training is a premier certification designed to equip professionals with hands-on skills to navigate the entire biopharmaceutical value chain — from R&D to international commercialization.

This course provides skill competency of biopharma middle and top level managers. This course is ideal for the working professionals of biopharmaceutical industry. This comprehensive biopharma global management training involves the real life job simulation. Hence, the course provides practical knowledge. Moreover, this course focuses on how biopharma business development, strategic management, regulatory and licensing professionals work in the company. Therefore, it helps advance professionals to acquire cutting edge business skills. 

In these online self-paced modules, participants understand about the development to commercialization process in detail. In other words, you will understand portfolio strategic management. Hence, the course covers fundamentals to advance learning on various skill areas. 

Course Snapshot

  • Course Code: RYD-093
  • Title: Executive PG Certification in Biopharma Global Business (EPBioGB)
  • Type of the course: Self paced Online Course. Hence this course can be accessed online across anywhere 24×7. Moreover, you can attend the course at your convenience in your flexible time. For example, if you want to attend the session at 11 pm at night, you can do that.
  • Course Duration : 1 Year
  • Course Certification: Certificate will be provided at the end of the successful completion of the course.

Why Join This Program?
This executive-level course bridges science, strategy, and business — helping you transform from a scientific or commercial professional into a global biopharma business strategist.

Who should attend this course? 

  • Those who are working in biopharmaceutical industry.
  • Professionals who are working in the regulatory affairs and related department.
  • Professionals from corporate and strategic management. 
  • This course suits those who are handling the biopharmaceutical development and licensing department.
  • This pharma global management course is ideal for the senior management professionals working in biopharmaceutical project management.
  • Anyone requiring an overview and detailed understanding on working of biopharmaceutical management. 
  • Fresher or beginners, Those who want to make a career in the management in pharmaceutical and biopharmaceutical companies.

What You’ll Learn in This Exclusive Program:

The Executive Program in Biopharma Global Business offers a complete, end-to-end understanding of how the global biopharmaceutical industry operates — blending science, business, and strategy through real-world case studies and simulations.


Biopharma R&D and Innovation Management
To begin with, the course provides a deep understanding of biopharmaceutical research and innovation. You’ll explore the entire drug discovery and development process — from target identification and pre-clinical studies to clinical trials and regulatory submissions. Moreover, you’ll learn how biologics and biosimilars are developed, regulated, and positioned in the global market.

Hands-On Simulations and Real-World Experience
Unlike conventional programs, this executive course emphasizes experiential learning. You will engage in hands-on simulations covering biopharma R&D, valuation, licensing, forecasting, and market access. As a result, you’ll gain the ability to make strategic, data-driven decisions that mirror real industry challenges.

Valuation, Licensing, and Business Development
Furthermore, the program covers how to evaluate biopharmaceutical assets, determine their market potential, and negotiate licensing deals. You’ll learn to manage in-licensing and out-licensing processes, partnerships, and collaborations, which are vital for driving business growth in the biopharma ecosystem.

Forecasting, Pricing, and Reimbursement Strategies
In addition, learners will build advanced skills in biopharma forecasting, pricing, and reimbursement models. The course also covers HEOR (Health Economics and Outcomes Research) and Real-World Evidence (RWE) — critical tools that influence market access, payer negotiations, and global pricing decisions.

Global Market Access and Commercialization
Moving beyond theory, the course takes a deep dive into regulatory affairs and global market access. You’ll explore how to navigate regulations for innovator biologics and similar biologics, including marketing authorization, post-approval variations, and global compliance. This module ensures that you are well-prepared to handle product launches across regulated and emerging markets.

Strategic and Brand Management
Equally important, you’ll gain skills in strategic management and brand leadership for biopharmaceutical products. Learn how to design, position, and manage brands effectively across their lifecycle — from early-stage development to global expansion.

International Marketing and Export Operations
Additionally, this program provides hands-on insights into biopharma international marketing, export documentation, and supply chain management. You’ll understand how to manage global logistics and compliance while expanding into new markets.

Advanced Digital Marketing for Biopharma
Finally, you’ll explore the fast-growing domain of digital transformation in biopharma marketing. Learn to build omnichannel digital strategies for biologics and biosimilars, integrating tools like analytics, automation, and online engagement to strengthen your global marketing impact.

Features of Biopharma Global Business

  • This biopharma global business training covers all aspects of the strategic management from drug discovery development, market access, pricing, forecasting, regulatory, marketing, branding, business development, licensing and sales. Hence the course provides
  • The course provides orientation to job related practical aspects of the business development managers. Therefore, on completion of the course, the participants will develop hands-on understanding of how Business Development Professional works.
  • One of the important features of the course is real life simulation on critical decision making processes. Hence, these simulations help to enhance the licensing and  decision making skills which are the core aspects of the pharmaceutical management working.

Case Based Learning is the key in biopharma global business course

  • Advance training on biopharmaceutical strategic management based on the various business regions.
  • Course covers regional biopharmaceutical business development requirements specific to US, EU, Middle East, GCC, MENA, African, ASEAN, Latam, China, Japan, India etc.
  • Access to Case Studies to learn about the drug commercialization steps. Hence, participants will develop advanced competency on biopharma strategic portfolio management.

Career in Biopharma Global Business

One of the fastest growing industries in is biopharmaceuticals. Hence the job market offers multiple opportunities for life science professionals as biotech companies work everyday to create successful products and place them in the marketplace. In biopharmaceutical industry scientists and researchers are key people who always preferred because of their biopharma subject knowledge. While these individuals have the academic and scientific background, they may not have the strategic management skills to manage biopharmaceutical business. Hence, this course provides necessary training to skill up the biopharmaceutical professionals.

In biopharmaceutical industry, strategic manager oversee the process of discovery, development and commercialization. They determine the biopharmaceutical products scope, timelines, budget and procurement, market access, regulatory, quality controls, marketing strategies, etc.

What are the areas biopharma global business professionals can make a career in biopharmaceutical company?

Biopharmaceutical Global Business Professionals will have option to join or work in following departments :

  • R&D Project Management
  • Strategic Management
  • Market Access
  • Global Pricing
  • Regulatory Affairs
  • Business Development
  • Licensing Department (Inlicensing or Outlicensing)
  • Brand Management
  • Marketing and Sales Management

Specific Knowledge of the various business regions is important for biopharmaceutical business management

There is no doubt that the biopharmaceutical industry is growing at a rapid pace. In fact Biologic is the future of medicine. However there is a rising concern over the safety and efficacy. Hence, the major objective of the biopharmaceutical management professionals is to learn various regional regulatory and business development knowledge. In fact, regional biopharma knowledge will help them to become successful in international business management. Moreover, the biopharma business development landscape is evolving and changing every other day. Biopharma management professionals must have thorough knowledge about the updated regulations. Sound regulatory knowledge helps them to take strategic decisions effectively. Therefore, this course is an ideal choice for the biopharmaceutical management course which covers various domains.

Section 1Biopharma Biopharma R&D Project Management & Timeline
Lecture 1R&D Process - Discovery to Commercialization
Lecture 2Investigational New Drug Application (INDA)
Lecture 3New Drug Application (NDA) 
Lecture 4Biological Licensing Application (BLA)  | 351(a) application | Form 356h | Differentiation with NDA | Timeline | Handling FDA queries
Lecture 5Basic concept and understanding of the Generic Drug
Lecture 6Abbreviated New Drug Application (ANDA) 
Lecture 7Abbreviated Biosimilar Application - 351(k): Advance Strategic Planning Process : Originator Vs. Biosimilar Development and Regulatory Approval Process | Reference Biologic | Purple Book | Data Requirements
Lecture 8505(j) ANDA, 505(b)(2) NDA, 505(b)(1) NDA
Lecture 9Vaccine development and approval Process
Lecture 10Handling of orange book
Lecture 11Purple Book: Significance | Searching | Assignments
Lecture 12Clinical Trials Terminologies 
Lecture 13Clinical Trial Protocol Writing
Lecture 14Ethics in Clinical Research
Lecture 15Informed Consent | Practical Training on preparing ICF | Ready Templates
Lecture 16Importance of Project Management in Biopharmaceutical Industry 
Lecture 17Traditional Project Management Vs. BioPharma Project Management | Key Differences | Different Parameters 
Lecture 18Key Comparison of Traditional and Pharma Project Management
Lecture 19Regulatory Influences on Biopharma Project Timelines and Deliverables
Lecture 20Case Study: Managing a New Drug Development Project with Strict Regulatory Timelines
Lecture 21Core Identified Phases of the Pharmaceutical Project Lifecycle
Lecture 22Terminologies of Pharmaceutical Project Management 
Lecture 23Project Tracking 
Lecture 24Asset Tracking 
Lecture 25Role and Responsibility of Project Leader
Lecture 26Project Constraint & Effective management of Project Constraint | Role of Project Manager
Lecture 27Critical Success Factor in Drug Development Projects
Lecture 28Project Management Case Study | Exploring the Project Tools Used in real life project
Section 2Biopharmaceutical Management and Regulation
Lecture 29Introduction : Biopharmaceuticals
Lecture 30Classification of Biopharmaceutical 
Lecture 31Important Concept regarding Biopharmaceuticals
Lecture 32Introduction to Biologics and Biosimilar | Key differences | Concept of Reference Product
Lecture 33Key features of Biologic | Differences in Chemical Drug Vs. Biologic Drugs
Lecture 34Principle of Naming of Biologic | Understanding on MAB naming system
Lecture 35Global Biopahrma Market Trends
Lecture 36Recombinant protein
Lecture 37Monoclonal Antibodies Vs. Polyclonal Antibodies
Lecture 38Monoclonal Antibodies
Lecture 39Synthetic Immunomodulators
Lecture 40Production of Monoclonal Antibodies
Lecture 41Cytokines
Lecture 42Interferon
Lecture 43Erythropoiesis-stimulating agent
Lecture 44Vaccine development and approval Process
Lecture 45Biosimilar Development Process
Lecture 46Strategic Consideration for Biosimilar Development 
Lecture 47Bio-Manufacturing Process Information
Lecture 48Studies required for approval of biosimilar
Lecture 49REMS Strategic Planning 
Lecture 50ATMPs | Types and Classification | Regulatory Mechanism 
Lecture 51mAB - At a glance
Lecture 52ATMPs - at a glance
Lecture 53CAR-T Therapy | Different Types of CAR-T Therapy | Mechanism of action | Challenges | Brainstorming on Concept of Personalized Medicine | Understanding on marketed formulation
Lecture 54Live Biotherapeutic Products | LBPs | Class | Mechanism | Indication Positioning | Regulatory Requirements for LBPs 
Lecture 55Regulatory Requirements for Biosimilar | Stepwise evidence based development | Analytical Similarity | Clinical Study | PKPD study requirements | CMC expectation of Biosimilar
Lecture 56Studies required for approval of biosimilar
Lecture 57Comparability of Biologics | Different Categories of Comparability | General Principles 
Lecture 58CQA (Critical Quality Attribute) and CPP (Critical Process Parameter)
Section 3Biosimilar Market Access
Lecture 59Biosimilar Approval and Patent Management | Strategic Pathway of Patent Negotiation and Litigation in Biosimilar Approval | Patent Dance | FAQs on Biologic Patent Management 
Lecture 60Biosimilar launch case study | Patent Dance Framework
Lecture 61Biosimilar Launch Framework 
Lecture 62Biosimilar 180 Day Notice 
Lecture 633(A) List | Significance | Importance | How to interpret
Lecture 64Steps to win over innovator patents | Step wise planning 
Lecture 65Biosimilar Launch Project Roadmap with defined stages of project
Lecture 66Timing of Biosimilar Submission and Approvals | Two Scenario based timeline assessments 
Lecture 67Hands on Training on Reference Biologic Patent | Classify RPS Biologic Patents | Case Simulation  
Lecture 68How to work on RPS’s Patent | Walkthrough | Case Study
Lecture 69Biosimilar Launch Project With Milestones
Lecture 70Analysis of Biologic Patents | Work Assignments
Lecture 71Biologic Patent Insight Worksheet
Lecture 72Patent Thickets | Concept | Implication | Case Based Learning 
Section 4Biopharma Market Access & Pricing - Forecasting - Formulary Placement of brands
Lecture 73Introduction to Market Access | Objectives | Various Key Terminologies | Steps of Market Access | Understanding on Pricing and Reimbursement
Lecture 74Market Access Functions : Role and Responsibilities | Key Job Areas | Understanding Job Description
Lecture 75Market Access Strategic Planning
Lecture 76Indication Sequencing | Indication Prioritization | Development of Indication Timeline | Indication Matrix | Value Based Indication Prioritization
Lecture 77Indication Prioritization Case Study
Lecture 78Market Access Value Dossier : What it is | Significance | Components | What to include
Lecture 79AMCP Market Access Value Dossier Preparation
Lecture 80Drug Pricing Methodologies
Lecture 81Sales Forecasting in Life Science Industry
Lecture 82New Product Forecast Algorithm
Lecture 83Patient Based Forecasting Model | Applying more filters and variables
Lecture 84Prescription Based Forecasting Model | Differences between Patient Based and Prescription Based Forecasting Model | Which model to use and when?
Lecture 85Prevalence Vs. Incidence Model
Lecture 86EPI Based Forecasting | Sales Based Forecasting | When and where to apply which forecasting model
Lecture 87Sales Forecasting Tools | New Product Forecasting | In Market Forecasting
Lecture 88Market Size Assignment 1 [Oncology Brand] - Applying sales forecasting tools to carry out next 6 years sales forecast | Excel Based Model
Lecture 89Market Size Assignment 2 [Asthma Brand] - Applying sales forecasting tools to carry out multiple years sales forecast | Excel Based Model
Lecture 90Formulary Placement | Different Tiers | How to classify the medication in different tiers | Formulary negotiation process | Rebates | Copay differential | Step-edits | Case Simulations - teasers
Lecture 91Patient Based Model Vs. Patient Flow Model | Critical Differences in Model | Concept of Black Box in Patient Flow Model | Application of both model
Lecture 92Concomitancy and polypharmacy | How it alter the basic forecasting algorithm | Practical Working | Comorbidity
Lecture 93Forecasting Techniques | Simple Conjoint-type Models | Zipf's Law | Simple Elasticity Model | The Bass Model |Simple Extrapolation
Lecture 94Simulation on Bottom-up forecasting
Lecture 95Assessment on Bottom-up forecasting
Lecture 96Oncology Brand Forecasting
Lecture 97Authorized Geenric
Lecture 98Branded Generics | Differences from Authorized and Unbranded Generics | Strategic planning for formulary placement 
Section 5Biopharma Strategic Management
Lecture 99Patents Vs. exclusivity 
Lecture 100Patent & Exclusivity - Strategic Understanding | Patent Restoration| Orphan Drug Exclusivity (ODE) | NCE & NCI Exclusivity | GAIN Exclusivity | Pediatric Exclusivity | 180 days exclusivity
Lecture 101Orphan Drug Designation 
Lecture 102USFDA expedited programs
Lecture 103Advance study on Para IV Filing
Lecture 104Para IV Notices
Lecture 105Evergreening - Patent Life Extension Strategies
Lecture 106Pay For Delay Strategy
Lecture 107Compulsory Licensing
Lecture 108Licensing & Technology Transfer
Lecture 109In-Licensing Vs. Outlicensing
Lecture 110LOE Strategies for Innovator Brands with case study
Lecture 111Drug Repurposing
Lecture 112Advance understanding of the portfolio Management 
Section 6Advance Biopharma Regulations and Submission Management
Lecture 113505(j) ANDA, 505(b)(2) NDA, 505(b)(1) NDA
Lecture 114Advance Learning on 505B2 Pathway
Lecture 115Chemistry, Manufacturing & Controls 
Lecture 116Common Technical Document (CTD)
Lecture 117Introduction to Electronic Common Technical Document (ECTD)
Lecture 118Advance Practical Training on Dossier Preparation focusing on drug registration in export countries 
Lecture 119Modules on Stability Study : Stability Study - Fundamental Understanding | Interchangebility | Reports | API & FPP Stability Study
Lecture 120Importance of effective dossier management
Lecture 121Certificate of Analysis
Lecture 122Detailed Understanding on ANDA Submission Dossier 
Lecture 123Prior Approval Submission 
Lecture 124Detailed Understanding on 505(b)(2) VS. Suitability Petition : Case Based Learning
Lecture 125NCE Vs. 505b2 application - Case Based Learning 
Lecture 126FTF - 180 Days Exclusivity - Case Based Learning
Lecture 127Classic case study of the 505b2 filing : Case Based Learning
Lecture 128Strategic Planning in Combating 30 months stay strategies of innovator company- Case Based Learning
Lecture 129Discussion on 85 common deficiency in CTD submission dossier
Lecture 130Electronic Batch Record for effective compliance management | Key Understanding | Functionalities | Importance in managing data integrity
Lecture 131PKPD in Drug Discovery | PK-PD trial | Understanding PKPD from regulatory perspective in drug approval process
Lecture 132Bioequivalence Study | Study design | Different types of BE Studies
Lecture 133Bioequivalence Study | Study design | Parallel Study | Crossover study design | Other alternative study designs | Blood Sampling Planning  | Analyte | Bioanalytical Methods Validation  | Statistical Model  | Ln Transformation  | Dose normalization | Confidence interval acceptance criteria
Lecture 134Establishment Inspection Report | 483 Observations | USFDA Warning Letter | Handling of FDA inspection | Closing of Warning Letter 
Lecture 135Data Integrity issues in Pharmaceutical Industry
Section 7Biopharma International Business
Lecture 136Introduction to Pharmaceutical Export
Lecture 137Introduction of Export Documentation | Understanding of important terminologies
Lecture 138Proforma Invoice - Detailed understanding how to prepare Proforma Invoice
Lecture 139Export Contract | Importance | Considerations | Things to include in Export Contract
Lecture 140Commercial Invoice | Importance | Differences with Proforma Invoice 
Lecture 141Custom House Agent | Role, Responsibilities, How they work | Freight Forwarder - Difference with CHA | Case Study
Lecture 142Letter of Credit | How it works | Different types of LC | LC terms and conditions | Sight LC | Case Studies
Lecture 143Bank Guarantee (BG) | How BG works | Differences between BG and LC | Applicability of BG
Lecture 144LC Discounting | How it works | How to calculate the LC discounting
Lecture 145Packing List | Importance | Things to include in packing list
Lecture 146Incoterms | 2020 Incoterms | Practical understanding on different types of Incoterms | Choosing the right incoterm
Lecture 147Logical selection of Incoterms | Landing in right incoterms for your business
Lecture 148Pre-shipment Certificate | COO |CVO| Fumigation Certificate | Preshipment Inspection Certificate | Certificate of Health
Lecture 149Transport Documents | Bill of Lading | Different Types of Bill of Lading | Airway Bill
Lecture 150Airfreight calculation | Gross Weight | Tare Weight | New Weight | Volumetric Calculation | Freight rate calculation
Section 8Real World Data and Real World Evidence
Lecture 151Evidence Based Decision Making | Combine evidences for decision making | Do we need more evidence? 
Lecture 152RWD and RWE | Potential sources of RWE | Traditional RCTs vs. RWE | Case Study - RWE Programs | Influencing HCP decision-making
Lecture 153RWD and RWE in Product Lifecycle Management
Lecture 154RWD and RWE - Fit to use | Assessment 
Lecture 155RWD data sources | Different types | Detailed understanding of each class 
Lecture 156RWD Study Design
Lecture 157RWE Published Tool | Insights on commonly used tools
Lecture 158RWD Study Design
Lecture 159Healthcare Reimbursement Models : Value Based Care | Fee for Service (FFS) Model | Other Reimbursement Models
Lecture 160HEOR Consensus Narrative Review 
Lecture 161Electronic Patient Data | EMR | EHR | Differences | Software architecture and characteristics
Lecture 162Active Surveillance Schemes | Active Case Finding |Sentinel Surveillance | Cohort Studies | Vaccine Safety Surveillance | Pharmacovigilance Programs | Disease Registries |Event Monitoring
Lecture 163RWD Characteristics
Lecture 164RCT vs. RWE Comparison | Case Based Analysis
Lecture 165RCT and RWE Comparison
Section 9Working on Real World Datasets
Lecture 166Introduction to Healthcare Datasets
Lecture 167Dataset 1: Claims Data (Insurance)
Lecture 168Dataset 2: Retail Pharmacy Prescription Data
Lecture 169Dataset 3: Longitudinal Patient Data
Lecture 170Characteristics of Different Set of Healthcare Data
Lecture 171Reimbursement and Pricing Datasets
Lecture 172RWE Data Sources & Quality Considerations Checklist | Case Based Analysis
Lecture 173Triangulation and benchmarking | Enhancing Data Validation Through Cross-Referencing
Lecture 174RWD & RWE Case Database
Lecture 175RWE Large Dataset for Data Crunching Exercises |Data cleaning & preprocessing | Comparative Effectiveness Analysis 
Section 10Biopharma Business Development | Licensing
Lecture 176Training on Basic Finance  |  Understanding Financial Statment | Income Statement | Balance Sheet | Cash Flow Statement
Lecture 177Moving Average | Moving Annual Total | YTD | How to calculate 
Lecture 178Compound Annual Growth Rate | CAGR Calculation
Lecture 179Business Development Job Functionality | Strategic Planning Process | Knowledge Area of Business Development | Lead targeting | Licensing term sheets
Lecture 180Portfolio Management Process | Portfolio Characteristics | Portfolio Analysis | Balancing the Portfolio | BD and Strategic Planning Department 
Lecture 181Identifying the corporate Need of business development | Objective – Strategy - Tactics | Portfolio constraints | SWOT | Numerical SWOT
Lecture 182Profiling and Searching | Objectives | Search Database | Creating Opportunity Anatomy for deal analysis | Mind Mapping | Searching Tools and Techniques - Web Search | Conference | Confidentaility - CDA | MTA
Lecture 183Numerical SWOT Practical training
Lecture 184Modelling and Deal Valuation - Top Down Model | Epidemiology data method | Complex Model | Forecasting | Heuristic or ‘prophesy’ method | Different value perspectives | Deal Structuring Structuring the deal
Lecture 185Market Size Determination - Market Share | Relative Market Share | Total Vs. Actual Vs. Penetrated Market
Lecture 186Forecasting : Tools and Techniques
Lecture 187Market Sizing & Forecasting Case Study
Lecture 188Royalty Management - Royalty structuring | Royalty Calculation Method| Tiered Royalties | Terms | Royalty Reductions | Royalty Stacking - Concept and Calculation | Minimum Annual Royalties | Reach through royalties
Lecture 189Average Royalty Rate
Lecture 190Factor affecting the Royalty Rate in Pharmaceutical and Biopharmaceutical Deal
Lecture 191Distribution Licensing | Geography | Indication Splitting | Exclusive and Non-Exclusive Licensing | Sub Licenses
Lecture 192Acquisition in Pharma  | Product Acquisition| Company Acquisitions| Steps in acquisition | Financing acquisition deals | Trademark Assignment Process
Lecture 193Joint Ventures in Pharmaceutical and Biopharmaceutical Industry
Lecture 194SPECIAL PURPOSE VEHICLES (SPV)
Lecture 195Indication Splitting | Concept | Implementation feasibility analysis 
Lecture 196Types of Deals from Discovery to Commercialization
Lecture 197What are the fundamental areas of business development
Lecture 198Licensing Term Sheet | Content Structuring | Sample Term Sheet
Lecture 199Licensing Payment Schedule | Case Study 
Lecture 200Valuation Methods: DCF | rNPV | Sunk Cost Method | Comparables | Sum of Parts | Deterministic Vs. Probabilistic rNPV |  Peak Sales - Max-Min Approach
Lecture 201Valuation Methods: EBITDA method of valuation | Enterprise Value and Enterprise Multiple Calculation
Lecture 202Negotiation Skill Training for BD personnel | Mind Mapping Tools | Practical Case Based Learning | Do and Don’ts in Pharma Business development Negotiations | Role of Scribes
Lecture 203Business Development Simulation and Decision Making | Early Stage VS. Late Stage Valuation Methodology | Stair Step Model
Lecture 204Types of Strategic Alliances: Unilateral technology licensing | Cross technology licensing | R&D contracts | R&D collaborations | Minority-equity-based R&D alliances | JV | Manufacturing and marketing agreements | big pharma firms with dedicated biotechnology firms 
Lecture 205Benchmarking | Benchmarking through consortium | How to use benchmarking for drug discovery development projects 
Lecture 206DCF Calculation : Concept and Calculation - Step by step understanding
Lecture 207Net Present Value (NPV) method : Calculation
Lecture 208Risk-Adjusted Discount Rate Method - Calculation | Concept of Risk Premium 
Lecture 209Valuation Metric - P/E Ratio and EPS : Calculation
Lecture 210Comparable Company Analysis method : Calculation
Lecture 211EBITDA Multiples | Importance in Pharma Biopharma BD&L | Calculation | Benchmarking EBITDA multiplies | Sourcing EBITDA multiples | Decoding EBITDA multiples value in different types of pharma and biopharma organizations
Lecture 212Pipeline Benchmarking | Significance and Importance in Bio Pharma BD&L | Analyzing sample portfolio | Comparative outcome in business development 
Lecture 213Comparative pipeline benchmarking analysis | Level of Benchmarking | Primary - Secondary - Tertiary Benchmarking Metrics | Case Based Analysis of three companies comparative pipeline benchmarking
Lecture 214Pipeline Diversity Scores | Significance | How to Calculate | Comparative Study of Pipeline Diversity Scores
Lecture 215Assignment: Prepare real time tracker
Lecture 216Research Productivity Index | Concept | Significance | Calculation Methodology | Comparative RPI benchmarking Exercise 
Lecture 217WACC in Biopharma Valuation | Significance | WACC benchmarking 
Lecture 218WACC Calculation | Step by Step Calculation | Insight on WACC components
Lecture 219rNPV Model | Step by Step Calculation | Insight on Probability and Cumulative Probability | Factoring WACC for Discounting 
Lecture 220Probability and Cumulative Probability | Calculation | Benchmarking | Factoring for WACC and rNPV 
Lecture 221Real Options Valuation (ROV) for Biopharma assets | Model Development | Calculation | Case Based Insight in the context of inlicensing and outlicensing | Early stage asset valuation with ROV
Lecture 222ROV Scenario Based Case Study
Lecture 223Biotech Decision Tree Model with Decision Reasoning
Section 11Biopharma Digital Marketing
Lecture 224Introduction to Digital Marketing 
Lecture 225Inbound and outbound marketing in pharma | Types of inbound and outbound marketing 
Lecture 226Digital Media Marketing Macro-Environment Analysis | Mapping of online market place | Internet marketing conversion process | Conversion Process Digital VS. Traditional | Publisher revenue model | Affiliate revenue model
Lecture 227Digital Media Marketing Micro - Environment Analysis | Web server | Web browser | http vs. https - Significance and hands on understanding | Privacy and ethical issues in internet marketing
Lecture 228Digital marketing strategy development | Planning process | E-Marketing Plan | Planning for MNC Vs. Start Up | Strategic Outcome measurement
Lecture 229Relationship marketing using digital platform | CRM | Concept of permission marketing | User Satisfaction and loyalty management | Feedback mechanism
Lecture 230Campaign planning for digital media | Goal setting | Tracking | Campaign insight | Segmentation and targeting | Message Development | Media Mix Selection | Media scheduling | Practical understanding to campaign performance matrics | CPC | CPA | PPC | ROI | CPS
Lecture 231Search Engine Optimization | Search Engine Marketing | Social Media Marketing
Lecture 232Web Host - Check the hosting details 
Lecture 233Page Speed- importance and practical understanding | Check the web speed 
Lecture 234Keyword | Keyword Planning for SEO and SEM | Keyword Planner
Lecture 235Mobile Responsive | Tracking the Site 
Lecture 236HCP sites and Patient Site
Lecture 237Google Ad - Practical Training on Campaign Development and Execution
Lecture 238Digital Marketing Strategies for innovator brand | Pre launch - comuing soon, DSE Marketing | Launch activities - Day of approval (DOA) site | FDA Compliance | FDA 2253 Filing
Lecture 239Brand Portal Development
Lecture 240Relationship Marketing : KOL Management and Patient Advocacy Group 
Lecture 241Public Relation - PR firm | PR Campaign | Press Release | Technical understanding of press release writing | Digital Press Release
Lecture 242Developing Ad - Pharmaceutical Prescription, OTC Vs FMCG Brands
Lecture 243Difference between FMCG and OTC Brand Ad
Lecture 244Digital Marketing Techniques
Lecture 245Video Marketing
Lecture 246Video Marketing Techniques For Small Business Owners
Lecture 247Promoting Brand through Article Advertising and Marketing